Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Sodium hydride → 2-(6-(4-(2-Morpholinoethyl)piperazin-1-yl)pyrimidin-4-ylamino)thiazole-5-carbonitrile
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Sodium hydride | HCID 24758 | — |
| 반응물 | 2-Chlorothiazole-5-carbonitrile | HCID 1485222 | — |
| 반응물 | 6-[4-(2-Morpholin-4-ylethyl)piperazin-1-yl]pyrimidin-4-amine | HCID 21934600 | — |
| 생성물 | 2-(6-(4-(2-Morpholinoethyl)piperazin-1-yl)pyrimidin-4-ylamino)thiazole-5-carbonitrile | HCID 10111613 | — |
반응 단계
6-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]pyrimidin-4-amine 7-4 (1.5 g, 5.13 mmol), sodium hydride (0.41 g, 10.26 mmol) and 2-chloro-1,3-thiazole-5-carbonitrile 2-2 (0.74 g, 5.13 mmol) were treated as in Scheme 4 above. The product was purified on a silica column eluted with DCM:MeOH:NH4OH (95:5:0.5 and 9:1:0.1) and isolated directly from the appropriate fractions after they were concentrated and the residue was suspended in methanol and filtered. 1H-NMR (CDCl3): 9.27 ppm (s, 1H); 8.45 ppm (s, 1H); 7.90 ppm (s, 1H); 5.87 ppm (s, 1H); 3.72 ppm (m, 4H); 3.65 ppm (s, 4H); 2.57 ppm (m, 8H); 2.50 ppm (s, 4H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07115597B2 |
| 출처 데이터셋 | uspto-grants-2006_10 |
| ORD ID | ord-b024a20a82de4e53adb1a9b072bbe885 |
| 출처 메모 | uspto-grants-2006_10 |